The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Are novel therapeutics replacing ASCT?
Hermann Einsele
• 14 Sep 2019
Prof. Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, outlines which patient populations allogeneic stem cell transplantations (ASCT) are most relevant, and whether novel therapeutics now challenge this. This interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
